Their mechanism of action involves the inhibition of angiotensin-converting enzyme, the decreased activity of renin-angiotensin aldosterone system that permits and assists in sodium excretion and the increased formation of bradykinin and vasolidatory prostaglandins. IMPROVEMENT OF SOLUBILITY OF LOW SOLUBLE (BCS CLASS 2) DRUGS BY NOVEL DRUG SOLUTION DROPPED TECHNIQUE
